Roche India and Cipla Limited announced that the first batch of the Antibody Cocktail (Casirivimab and Imdevimab) is now available in India while a second batch will be made available by mid-June. In total they can potentially benefit 200,000 patients as each of the 100,000 packs that will be available in India offers treatment for two patients. Cipla will distribute the product by leveraging its strong distribution strengths across the country. The drug will be available through leading hospitals and COVID treatment centers.
- Read more about Roche Antibody Cocktail (Casirivimab and Imdevimab) is now available in India
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/roches-antibody-cocktail-casirivimab-and-imdevimab-is-now-available-in-india-cipla-to-market-it-pan-indi
No comments:
Post a Comment